Bayesian Capital Management’s Brookfield BN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,200
Closed -$329K 169
2025
Q3
$329K Sell
7,200
-8,250
-53% -$366K 0.07% 367
2025
Q2
$637K Buy
+15,450
New +$573K 0.1% 246
2022
Q4
Sell
-36,256
Closed -$799K 797
2022
Q3
$799K Sell
36,256
-9,278
-20% -$240K 0.16% 174
2022
Q2
$1.09M Buy
+45,534
New +$1.22M 0.2% 135
2022
Q1
Sell
-14,829
Closed -$483K 781
2021
Q4
$483K Sell
14,829
-33,228
-69% -$1.05M 0.15% 183
2021
Q3
$1.39M Buy
+48,057
New +$1.4M 0.4% 65
2021
Q2
Sell
-19,832
Closed -$472K 426
2021
Q1
$472K Buy
+19,832
New +$442K 0.11% 237
2020
Q1
Sell
-19,619
Closed -$405K 783
2019
Q4
$405K Buy
+19,619
New +$391K 0.07% 351

Other funds holding BN

Bayesian Capital Management's BN Position: Q4 2025 in Review

Bayesian Capital Management sold out of Brookfield (BN) in Q4 2025, closing a stake of 7,200 shares — an estimated $329K sold.

Bayesian Capital Management first reported a position in BN in Q4 2019 and held it in 8 quarters. The position peaked at $1.39M in Q3 2021. 936 funds tracked by Wall St. Rank hold BN as of Q4 2025.

  • Bayesian Capital Management reported no remaining Brookfield position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 7,200 Brookfield shares in Q4 2025, an estimated $329K.
  • Bayesian Capital Management first reported a position in Brookfield in Q4 2019 and held it in 8 quarters.
  • Bayesian Capital Management's Brookfield position peaked at $1.39M in Q3 2021.
  • 936 funds tracked by Wall St. Rank held Brookfield as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.